Walgreens Boots Alliance (NASDAQ:WBA) Issues FY25 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share guidance of $1.40-$1.80 for the period, compared to the consensus earnings per share estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Stock Up 27.5 %

Shares of WBA stock opened at $11.76 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock has a market cap of $10.15 billion, a PE ratio of -1.17, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64. The business’s fifty day moving average is $9.26 and its 200-day moving average is $9.85. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $24.93.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.66 earnings per share. Equities analysts expect that Walgreens Boots Alliance will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 8.50%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Wall Street Analyst Weigh In

WBA has been the subject of a number of analyst reports. Jefferies Financial Group reduced their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Barclays boosted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Finally, Royal Bank of Canada dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.